🇮🇹 Qubit Pharma, Italy & the Future of Pharmaceutical Research 🔬 We thank Quantum Italia for inviting us to speak at this great and insightful event on the impact of Quantum technologies on the future of pharmaceutical research 👏 Both our CEO Robert Marino and our Head of Quantum Computing, Alberto Peruzzo had a chance to present our vision for the future of drug discovery and our applied quantum research. They were impressed with the quality of the presentations and exchanges with guests and of course with fellow speakers Christophe Jurczak I Quantonation, Gabriele Morano & Simone De Liberato I Quantum Italia, Mauro D'Arcangelo I Pasqal, Martina Stella I Algorithmiq. We had a great time and we look forward to connecting again in the future! #QuantumItalia #DrugDiscovery #QuantumAidedDrugDesign
Qubit Pharmaceuticals’ Post
More Relevant Posts
-
Principal researcher of G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences
Exploring Arbidol's Conformational Behavior in Supercritical Carbon Dioxide: Unveiling 'Opened' and 'Closed' Conformer Groups In a groundbreaking study, researchers Konstantin V. Belov, Alexey A. Dyshin, and Ilya A. Khodov have delved into the conformational intricacies of arbidol, a pharmaceutical compound renowned for its broad applications in antiviral and immunomodulatory therapies. The research, published in the journal Molecular Liquids, focuses on arbidol's behavior in a supercritical carbon dioxide solution, shedding light on the compound's various conformers. https://lnkd.in/dNuwmK43
To view or add a comment, sign in
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dkdWMzY5 The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
Join us on September 26-28, 2023 at Merck Research Laboratories, Boston, MA. at the Applied Pharmaceutical Analysis 2023 In-Person Event. Shiny Rajan, PhD, Director of Tissue Engineering at Javelin Biotech, will be presenting a poster: “Development of a Novel Milli-fluidic Liver Tissue Platform for Mechanistic Pharmacokinetic (PK) and Drug-Drug Interaction (DDI) Studies”
To view or add a comment, sign in
-
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dz9Z8nXf The speakers Celestine Chi(AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
We are pleased to announce a collaborative agreement with the Universitat de Barcelona to develop and demonstrate new or enhanced applications of #NMR at 1 GHz for the pharmaceutical industry, especially in biologics and new drug modalities. The University of Barcelona installed in 2022 the first Avance Evo 1 GHz NMR instrument in Europe and is part of the Spanish Singular Scientific and Technical Large Scale Facilities network. The collaboration includes the synthesis of model therapeutic oligonucleotides by Dr. Terraza’s group at the University of Barcelona. Other therapeutics of interest are monoclonal antibodies, RNA, oligonucleotides, and peptides. This responds to the need to improve product risk assurance and the encouragement by the regulatory authorities to use state-of-the-art technology, including NMR. Read more: https://lnkd.in/dHYDJVD6 Centres Científics i Tecnològics de la Universitat de Barcelona (CCiTUB) #CCiTUB #Bruker #Pharma #Biomedicine #NMRchat
To view or add a comment, sign in
-
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dxJX5nwn The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/dNsHSDYW The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
On March 12, at 11 am EST, don't miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization". Register here: https://lnkd.in/d7NxaUjd The speakers Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) will discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals
To view or add a comment, sign in
-
-
We are pleased to announce a collaborative agreement with the Universitat de Barcelona to develop and demonstrate new or enhanced applications of #NMR at 1 GHz for the pharmaceutical industry, especially in biologics and new drug modalities. The University of Barcelona installed in 2022 the first Avance Evo 1 GHz NMR instrument in Europe and is part of the Spanish Singular Scientific and Technical Large Scale Facilities network. The collaboration includes the synthesis of model therapeutic oligonucleotides by Dr. Terraza’s group at the University of Barcelona. Other therapeutics of interest are monoclonal antibodies, RNA, oligonucleotides, and peptides. This responds to the need to improve product risk assurance and the encouragement by the regulatory authorities to use state-of-the-art technology, including NMR. Read more: https://lnkd.in/d_6zSrSu Centres Científics i Tecnològics de la Universitat de Barcelona (CCiTUB) #CCiTUB #Bruker #Pharma #Biomedicine #NMRchat
To view or add a comment, sign in
-
More from this author
-
Qubit Pharmaceuticals nominated for "Best Startup 2024" award by Prix Galien USA
Qubit Pharmaceuticals 1w -
Major breakthrough in quantum algorithms: Qubit Pharma and Sorbonne University drastically reduce the number of qubits needed to simulate molecules
Qubit Pharmaceuticals 1mo -
Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic Forum
Qubit Pharmaceuticals 2mo